ArticleBriefings in bioinformatics2026
BayesRare: Bayesian mixture model for population-level rare cell type detection in multi-subject single-cell RNA sequencing data.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rare cell types in single-cell RNA sequencing (scRNA-seq) data often encode essential biological signals, such as early disease markers or key immune regulators. With advancing technologies, large-scale scRNA-seq cohorts from multiple subjects now enable population-level analyses of the prevalence, heterogeneity, and disease associations of rare cell populations. However, existing methods for rare cell detection are typically limited to single datasets and cannot effectively leverage cross-subject information. To tackle this challenge, we present BayesRare, a hierarchical Bayesian framework for population-level rare cell discovery in multi-subject scRNA-seq data. The method augments a Bayesian mixture model with a rare cluster indicator, supporting joint cell-type clustering and rare-population identification. By explicitly characterizing the statistical properties of rare cell types, BayesRare integrates evidence across subjects, quantifies uncertainty via posterior probabilities, and enables inference of group-level differences (e.g. patients versus controls). Across synthetic and three real datasets, BayesRare achieves superior precision, reduces false positives, and uncovers biologically meaningful disease-specific rare subtypes. The R package of BayesRare is available at https://github.com/yinqiaoyan/BayesRare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.